Abstract: Disclosed herein are new graft copolymers of dextran and polyacrylamide. The graft copolymers can include dextran, where the dextran is a backbone polymer including about 15 wt % to about 50 wt % of the graft copolymer; and polyacrylamide, where the polyacrylamide is a side chain polymer including about 50 wt % to about 85 wt % of the graft copolymer, based on the total weight of the graft copolymer, where the graft copolymer has a weight-average molecular weight from about 1,000,000 g/mol to about 1,500,000 g/mol. The graft copolymers of dextran and polyacrylamide can be used as friction reducers for well treatment fluids.

Abstract: Disclosed herein are new graft copolymers of dextran and polyacrylamide. The graft copolymers can include dextran, where the dextran is a backbone polymer including about 15 wt % to about 50 wt % of the graft copolymer; and polyacrylamide, where the polyacrylamide is a side chain polymer including about 50 wt % to about 85 wt % of the graft copolymer, based on the total weight of the graft copolymer, where the graft copolymer has a weight-average molecular weight from about 1,000,000 g/mol to about 1,500,000 g/mol. The graft copolymers of dextran and polyacrylamide can be used as friction reducers for well treatment fluids.

Abstract: Disclosed herein are new graft copolymers of dextran and polyacrylamide. The graft copolymers can include dextran, where the dextran is a backbone polymer including about 15 wt % to about 50 wt % of the graft copolymer; and polyacrylamide, where the polyacrylamide is a side chain polymer including about 50 wt % to about 85 wt % of the graft copolymer, based on the total weight of the graft copolymer, where the graft copolymer has a weight-average molecular weight from about 1,000,000 g/mol to about 1,500,000 g/mol. The graft copolymers of dextran and polyacrylamide can be used as friction reducers for well treatment fluids.